Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ARCT
$15.05
+15.46%
ARCT
· Arcturus Therapeutics Holdings Inc.
$15.05
+2.02 (+15.46%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$389.82M
Shares
28.42M
Volume · Oct 5
962.77K
Avg daily vol (3M)
919.97K
All webcasts
Earnings call · FY2026 Q2
Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2026 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$2.96M
-89.5% YoY
Diluted EPS
-$0.84
Net income
-$23.79M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document